MITRUSOR-25/50ER

Experience effective relief for urinary bladder control with MITRUSOR-25/50ER Mirabegron Extended Release Tablets, a medication that contains either 25mg or 50mg of Mirabegron, a selective β3-AR (beta-3 adrenergic receptor) agonist. These extended-release tablets are designed to target and enhance the function of the detrusor muscles of the urinary bladder, offering a solution for managing urinary incontinence and related conditions.

Key Ingredient:

• Mirabegron (25mg/50mg): Mirabegron is a selective β3-AR agonist that acts on the detrusor muscles of the urinary bladder. It helps to relax these muscles, increase bladder capacity, and reduce the frequency and urgency of urination. This medication is particularly effective for managing overactive bladder (OAB) symptoms.

Benefits for Bladder Control:

MITRUSOR-25/50ER Extended Release Tablets offer relief for individuals dealing with urinary incontinence and OAB by:

• Reducing the frequency of urination
• Decreasing urgency to urinate
• Enhancing bladder capacity
• Improving control over bladder function

Extended-Release Formula:

These tablets are formulated with an extended-release mechanism, allowing for sustained action over time. This means you can experience the benefits of Mirabegron without the need for frequent dosing.

Usage Instructions:

• Take MITRUSOR-25/50ER Mirabegron Extended Release Tablets as directed by your healthcare provider.
• Swallow the tablets whole with a glass of water, typically once a day.
• Follow the prescribed dosage to effectively manage urinary incontinence and related conditions.

Caution:

• Use MITRUSOR-25/50ER Mirabegron Extended Release Tablets only as prescribed by a healthcare professional.
• Consult with your healthcare provider before starting or discontinuing this medication.
• Inform your healthcare provider of any existing medical conditions or medications you are currently taking.